Wordt geladen...
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
In glioblastoma multiforme (GBM), both temozolomide (TMZ) and cisplatin are very active at various toxic levels. Previous studies demonstrated that cisplatin with the standard regimen of TMZ is active in patients suffering from recurrent GBM, generating a moderate level of toxicity. Also, continuous...
Bewaard in:
| Gepubliceerd in: | Medicine (Baltimore) |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer Health
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348180/ https://ncbi.nlm.nih.gov/pubmed/28272232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006261 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|